Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2017 (2017), Article ID 5375091, 5 pages
https://doi.org/10.1155/2017/5375091
Case Report

High-Risk Neuroblastoma with Metastases to Bilateral Kidneys at Diagnosis

1Department of Pediatrics, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan
2Department of Human Resource Development for Cancer, Faculty of Medical Sciences, University of Fukui, 23-3 Matsu-okashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan
3Department of Pediatrics, Japanese Red Cross Fukui Hospital, 2-4-1 Tsukimi, Fukui 918-8011, Japan
4Department of Tumor Pathology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan
5Division of Surgical Pathology, University of Fukui Hospital, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan

Correspondence should be addressed to Toshihide Yoshikawa

Received 25 January 2017; Revised 28 February 2017; Accepted 21 March 2017; Published 30 March 2017

Academic Editor: Denis A. Cozzi

Copyright © 2017 Toshihide Yoshikawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. G. DuBois, Y. Kalika, J. N. Lukens et al., “Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival,” Journal of Pediatric Hematology/Oncology, vol. 21, no. 3, pp. 181–189, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Escobar, J. L. Grosfeld, R. L. Powell et al., “Long-term outcomes in patients with stage IV neuroblastoma,” Journal of Pediatric Surgery, vol. 41, no. 2, pp. 377–381, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Filiatrault, C. Hoyoux, P. Benoit, L. Garel, and D. Esseltine, “Renal metastases from neuroblastoma—report of two cases,” Pediatric Radiology, vol. 17, no. 2, pp. 137–138, 1987. View at Publisher · View at Google Scholar · View at Scopus
  4. H. J. Sul and D. Y. Kang, “Congenital neuroblastoma with multiple metastases: a case report,” Journal of Korean Medical Science, vol. 18, no. 4, pp. 618–620, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. K. K. Matthay, C. P. Reynolds, R. C. Seeger et al., “Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study,” Journal of Clinical Oncology, vol. 27, no. 7, pp. 1007–1013, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. L. Yu, A. L. Gilman, M. F. Ozkaynak et al., “Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma,” The New England Journal of Medicine, vol. 363, no. 14, pp. 1324–1334, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Inoue, T. Nakano, A. Yoneda et al., “Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation,” Bone Marrow Transplantation, vol. 32, no. 1, pp. 103–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Marabelle, C. Paillard, A. Tchirkov et al., “Graft-versus-tumour effect in refractory metastatic neuroblastoma,” Bone Marrow Transplantation, vol. 39, no. 12, pp. 809–810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Goi, T. Inukai, H. Honna et al., “Successful tandem (autologous-cord blood) SCT in advanced neuroblastomas with highly amplified MYCN,” Bone Marrow Transplantation, vol. 46, no. 6, pp. 835–839, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Venstrom, J. Zheng, N. Noor et al., “KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma,” Clinical Cancer Research, vol. 15, no. 23, pp. 7330–7334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Carrega, I. Bonaccorsi, E. Di Carlo et al., “CD56brightperforinlow noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph,” Journal of Immunology, vol. 192, no. 8, pp. 3805–3815, 2014. View at Publisher · View at Google Scholar · View at Scopus